Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-10-07

FDA Approved: CLIMARA PRO — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Climara Pro (estradiol and levonorgestrel) submitted by Bayer, potentially updating labeling or expanding indica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLIMARA PRO (ESTRADIOL AND LEVONORGESTREL)

Snippet

SUPPL AP for CLIMARA PRO (ESTRADIOL AND LEVONORGESTREL)